product commercialization
proposed product
proposed project
disease diagnosis
new kit
GREEn Kit
π project
actual diagnostic systems
actual company asset
autoimmune disease
normative procedure
biopsy procedure
high incidence
EU market
specificity of diagnostic outcomes
definitive diagnosis of Sjogren’s Syndrome
ELISA tests
superior performance
clear definition
plants
set-up
different countries
spamming
virus-based particles
US markets
existing ones
basis
aspects
business strategy
proteinaceous nanomaterials
forecast needs
potential
novel
main advantages
distribution
patent
population
serious complications